Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy.
Simoni N, Rossi G, Benetti G, Zuffante M, Micera R, Pavarana M, Guariglia S, Zivelonghi E, Mengardo V, Weindelmayer J, Giacopuzzi S, de Manzoni G, Cavedon C, Mazzarotto R. Simoni N, et al. Among authors: guariglia s. Front Oncol. 2020 Nov 27;10:599907. doi: 10.3389/fonc.2020.599907. eCollection 2020. Front Oncol. 2020. PMID: 33330097 Free PMC article.
Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar.
Mazzarotto R, Simoni N, Guariglia S, Rossi G, Micera R, De Robertis R, Pierelli A, Zivelonghi E, Malleo G, Paiella S, Salvia R, Cavedon C, Milella M, Bassi C. Mazzarotto R, et al. Among authors: guariglia s. Front Oncol. 2020 Dec 17;10:600940. doi: 10.3389/fonc.2020.600940. eCollection 2020. Front Oncol. 2020. PMID: 33392093 Free PMC article.
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer.
Rossi G, Simoni N, Paiella S, Rossi R, Venezia M, Micera R, Malleo G, Salvia R, Giuliani T, Di Gioia A, Auriemma A, Milella M, Guariglia S, Cavedon C, Bassi C, Mazzarotto R. Rossi G, et al. Among authors: guariglia s. Front Oncol. 2021 Apr 20;11:662205. doi: 10.3389/fonc.2021.662205. eCollection 2021. Front Oncol. 2021. PMID: 33959509 Free PMC article.
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy.
Rossi G, Altabella L, Simoni N, Benetti G, Rossi R, Venezia M, Paiella S, Malleo G, Salvia R, Guariglia S, Bassi C, Cavedon C, Mazzarotto R. Rossi G, et al. Among authors: guariglia s. World J Gastrointest Oncol. 2022 Mar 15;14(3):703-715. doi: 10.4251/wjgo.v14.i3.703. World J Gastrointest Oncol. 2022. PMID: 35321278 Free PMC article.
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
Simoni N, Micera R, Paiella S, Guariglia S, Zivelonghi E, Malleo G, Rossi G, Addari L, Giuliani T, Pollini T, Cavedon C, Salvia R, Milella M, Bassi C, Mazzarotto R. Simoni N, et al. Among authors: guariglia s. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e31-e38. doi: 10.1016/j.clon.2020.06.019. Epub 2020 Jul 15. Clin Oncol (R Coll Radiol). 2021. PMID: 32682686
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Paiella S, Malleo G, Simoni N, Micera R, Guariglia S, Cavedon C, Marchegiani G, Esposito A, Landoni L, Casetti L, Tuveri M, Milella M, Secchettin E, Manzini G, Bovo C, De Pastena M, Fontana M, Salvia R, Mazzarotto R, Bassi C. Paiella S, et al. Among authors: guariglia s. BMC Cancer. 2021 Feb 16;21(1):165. doi: 10.1186/s12885-021-07877-7. BMC Cancer. 2021. PMID: 33593311 Free PMC article.
34 results